Magnetar Financial LLC
Institutional investor · Portfolio as of Q3 2023
Top Holdings435 positions
MERCK & CO. INC. | 1.3M | $132.5M | 3.4% | $89.68 | +6.93% | 8 qtrssince 2021-Q4 | Increased 89 |
ZIMMER BIOMET HOLDINGS INC | 1.1M | $123M | 3.1% | $118.99 | -7.59% | 3 qtrssince 2023-Q1 | Increased 89 |
ALBERTSONS COS INC - CLASS A | 4.7M | $106.2M | 2.7% | $19.33 | +10.01% | 4 qtrssince 2022-Q4 | Increased 52 |
MEDTRONIC PLC | 1.3M | $103.4M | 2.6% | $74.25 | -4.34% | 18 qtrssince 2019-Q2 | Increased 83 |
ABBOTT LABORATORIES | 1M | $100.1M | 2.6% | $93.95 | -3.15% | 3 qtrssince 2023-Q1 | Increased 56 |
NEW RELIC INC | 1.1M | $98.3M | 2.5% | — | — | 1 qtr | New 77 |
PNM RESOURCES INC | 2.1M | $93.6M | 2.4% | $40.59 | -0.59% | 12 qtrssince 2020-Q4 | Increased 54 |
BAXTER INTL INC | 2.4M | $91.4M | 2.3% | $46.46 | -23.08% | 18 qtrssince 2019-Q2 | Increased 74 |
ELANCO ANIMAL HEALTH INC | 7.9M | $88.7M | 2.3% | $13.20 | -14.83% | 12 qtrssince 2020-Q4 | Increased 65 |
CHURCHILL CAPITAL CORP VII | 8.3M | $86.8M | 2.2% | — | — | 7 qtrssince 2022-Q1 | Unchanged 0 |
NOVARTIS AG-SPONSORED ADR | 799,698 | $81.5M | 2.1% | $93.67 | +1.02% | 2 qtrssince 2023-Q2 | Increased 82 |
ABCAM PLC | 3.6M | $80.5M | 2.1% | — | — | 1 qtr | New 77 |
SPLUNK INC | 536,156 | $78.4M | 2.0% | — | — | 1 qtr | New 77 |
ACTIVISION BLIZZARD INC | 798,758 | $74.8M | 1.9% | — | — | 7 qtrssince 2022-Q1 | Increased 49 |
SEAGEN INC | 349,204 | $74.1M | 1.9% | — | — | 3 qtrssince 2023-Q1 | Increased 50 |
ENCOMPASS HEALTH CORP | 1.1M | $71.2M | 1.8% | $50.82 | +30.07% | 7 qtrssince 2022-Q1 | Decreased 0 |
CAPRI HOLDINGS LTD | 1.3M | $69.1M | 1.8% | $52.61 | 0.00% | 1 qtr | New 68 |
VMWARE INC-CLASS A | 400,947 | $66.7M | 1.7% | — | — | 6 qtrssince 2022-Q2 | Increased 50 |
HUMANA INC | 125,772 | $61.2M | 1.6% | $461.18 | +1.92% | 10 qtrssince 2021-Q2 | Increased 58 |
GSK PLC | 1.6M | $58.9M | 1.5% | $27.82 | +19.01% | 5 qtrssince 2022-Q3 | Decreased 0 |
Magnetar Financial LLC manages $3.9B across 435 positions as of Q3 2023. Top holdings: MRK (3.4%), ZBH (3.1%), ACI (2.7%). Fund DNA: Momentum Trader. HoldingsIntel Score: 3.5/5.0.
Active quarter - 217 new positions, 259 exits, 89 increased. Top move: MRK (INCREASED, conviction 89). Portfolio: $3.9B across 435 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR